维洛沙嗪治疗一名多动型自闭症儿童的早期阳性报告。
Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism.
作者信息
Naguy Ahmed, Alayadhi Nadyah, Pridmore Saxby, Alamiri Bibi
机构信息
Naguy, MBBch, MSc, MRCPsych (UK), Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Shuwaikh, State of Kuwait.
Alayadhi, BSc (Pharma, UK), MSc, PhD (UK), Pharmacy Department, KCMH, Kuwait.
出版信息
Psychopharmacol Bull. 2025 Jan 1;55(1):89-92.
Abstract
Herein, authors report on an ASD child with comorbid ADHD, ID, metabolic syndrome and nocturnal enuresis that failed multiple trials of psychotropic agents for behavioural dyscontrol. Viloxazine adjuventia brought about remarkable improvement spanning different domains. Purported pharmacodynamic mechanisms are briefly discussed. This case represents one of the earliest reports of viloxazine use in ASD.
摘要
在此，作者报告了一名患有共病注意力缺陷多动障碍（ADHD）、智力障碍（ID）、代谢综合征和夜间遗尿症的自闭症谱系障碍（ASD）儿童，该儿童在多次尝试使用精神药物治疗行为失控均失败。维洛沙嗪辅助治疗在不同领域带来了显著改善。本文简要讨论了其推测的药效学机制。该病例是维洛沙嗪用于ASD的最早报告之一。
相似文献
1
Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism.维洛沙嗪治疗一名多动型自闭症儿童的早期阳性报告。
Psychopharmacol Bull. 2025 Jan 1;55(1):89-92.
2
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
3
Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).自闭症谱系障碍（ASD）中易怒、攻击行为和自我伤害的药物干预。
Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD011769. doi: 10.1002/14651858.CD011769.pub2.
4
Response Trajectories and Temporal Trends of Viloxazine Treatment for Young People With ADHD: A Meta-Analysis.维洛沙嗪治疗青少年注意力缺陷多动障碍的反应轨迹和时间趋势：一项荟萃分析。
JAMA Netw Open. 2024 Nov 4;7(11):e2445885. doi: 10.1001/jamanetworkopen.2024.45885.
5
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍（ADHD）的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
6
A systematic review of randomized controlled trials on efficacy and safety of transcranial direct current stimulation in major neurodevelopmental disorders: ADHD, autism, and dyslexia.一项关于经颅直流电刺激治疗主要神经发育障碍（ADHD、自闭症和阅读障碍）的疗效和安全性的随机对照试验的系统评价。
Brain Behav. 2022 Sep;12(9):e2724. doi: 10.1002/brb3.2724. Epub 2022 Aug 8.
7
Aripiprazole for autism spectrum disorders (ASD).阿立哌唑用于治疗自闭症谱系障碍（ASD）。
Cochrane Database Syst Rev. 2016 Jun 26;2016(6):CD009043. doi: 10.1002/14651858.CD009043.pub3.
8
Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder.顺势疗法治疗注意力缺陷/多动障碍或多动障碍。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD005648. doi: 10.1002/14651858.CD005648.pub2.
9
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.患有共病抽动障碍的儿童注意力缺陷多动障碍（ADHD）的药物治疗。
Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3.
10
Memantine for autism spectrum disorder.美金刚治疗自闭症谱系障碍。
Cochrane Database Syst Rev. 2022 Aug 25;8(8):CD013845. doi: 10.1002/14651858.CD013845.pub2.
本文引用的文献
1
Successful Add-on Viloxazine to Clozapine-Responsive Schizophrenia Mitigated Cognitive, Negative and Metabolic Domains.成功地在氯氮平反应性精神分裂症基础上添加维洛沙嗪，改善了认知、阴性和代谢领域。
Psychopharmacol Bull. 2022 Feb 25;52(1):57-60.
2
Newly FDA-approved psychotropic agents-a recap.美国食品药品监督管理局新批准的精神药物——综述
Asian J Psychiatr. 2021 Oct;64:102786. doi: 10.1016/j.ajp.2021.102786. Epub 2021 Jul 17.
3
Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD.自闭症谱系障碍中注意力缺陷多动障碍症状谱的药物治疗
J Nerv Ment Dis. 2017 Sep;205(9):738. doi: 10.1097/NMD.0000000000000723.
4
Successful Use of Sertindole for Severe Behavioral Dyscontrol in a Pediatric Case of Syndromic Autism Spectrum Disorder.在一例患有综合征性自闭症谱系障碍的儿科病例中，成功使用舍吲哚治疗严重行为失控
J Child Adolesc Psychopharmacol. 2017 Jun;27(5):471-472. doi: 10.1089/cap.2016.0182. Epub 2017 Mar 15.
5
Duloxetine Alleviates Stimulant Dysphoria, Helps With Enuresis, and Complements Cognitive Response in an Adolescent With Attention-Deficit/Hyperactivity Disorder.度洛西汀可缓解兴奋剂所致烦躁不安，有助于治疗遗尿症，并辅助改善一名患有注意力缺陷/多动障碍青少年的认知反应。
Prim Care Companion CNS Disord. 2016 Dec 29;18(6). doi: 10.4088/PCC.16l01957.
6
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder.奥氮平用于儿童/青少年广泛性发育障碍的双盲安慰剂对照试验性研究。
J Child Adolesc Psychopharmacol. 2006 Oct;16(5):541-8. doi: 10.1089/cap.2006.16.541.
Zotero 插件